Guiding the path of treatment for individual cancer patients

Eutropics’ PraediCare Dx™ platform provides a biomarker technology for
accelerating drug discovery and development.

learn how

PraediCare Dx™

Eutropics is advancing personalized medicine by providing novel, predictive diagnostic tests that are
uniquely accurate in guiding patient cancer treatments.

Innovative leading cancer treatment response predictors

Demonstrated medical utility in blood cancers

CLIA certified tests for Acute Myeloid Leukemia

Validated tests for Chronic Lymphocytic Leukemia